This Week in Wellworthy: Energy, Advocacy and Access in Women’s Health & Chronic Illness

October 1, 2025

Every week, we track the biggest health policy and access stories shaping your care, your wallet, and your plate. Here’s what you need to know:

Energy, Advocacy and Access in Women’s Health & Chronic Illness

Energy isn’t just about what you eat or how much you rest. For those living with chronic illness, it’s shaped by access, research, and the policies that either support or obstruct care. This week’s headlines highlight both the progress being made and the fragility of the systems we rely on.

Women’s Health & Chronic Illness Research

Highlights in Women’s Health This Week:

Why it matters: These advances point to progress, but until research translates into everyday care, people with these conditions are left managing fatigue, pain, and barriers to treatment largely on their own.

Policy Watch: Government Shutdown

As of this drafting, the U.S. government has officially shut down, and the ripple effects are already being felt across health and wellness systems.

What this means right now:

  • Healthcare programs: Community health centers, rural clinics, and support programs like WIC (Women, Infants, and Children) could see disruptions if the shutdown continues.
  • Food assistance: Millions who rely on SNAP may face uncertainty if funding lapses stretch out.
  • Medical research: The NIH and CDC are scaling back operations, pausing new trials, and limiting outreach.
  • Oversight gaps: FDA food safety inspections and monitoring could slow, leaving vulnerabilities in the supply chain.

Why it matters for chronic illness and wellness:
Shutdowns disproportionately impact vulnerable groups who already face barriers to consistent care and access to nutritious food. The longer it continues, the more strain it adds to systems that were already stretched thin.

Beyond the immediate disruption, repeated shutdowns erode trust in public health infrastructure and widen inequities. Advocacy and local community programs become even more essential stopgaps during times like this.

Preventable Risk Factors Still Drive Chronic Illness

Studies this week underscored how preventable risks continue to shape outcomes:

This reinforces the urgent need for prevention efforts and equitable access to nutrition, movement, and care.

Food, Medications & Access

Access to food and medication is also shifting.

  • GLP-1 medications are changing not just appetite but also how much people spend on food.
  • Community food programs, like Kansas City’s local food aid initiative, continue to disappear, leaving families without affordable, nutrient-rich options.
  • And the FDA is proposing tighter oversight of the GRAS process (Generally Recognized as Safe), the system companies use to self-certify additives.

Potential industry impacts:

  • More compliance costs, especially for smaller brands.
  • Slower innovation in supplements and functional foods.
  • Potential reformulation if legacy additives are reexamined.

Why it matters for chronic illness: Additives can influence inflammation, digestion, and energy. Stronger FDA oversight could mean safer food, greater transparency, and less hidden risk.

Next steps: The rule is still a proposal. A public comment period is expected, where both industry and consumers can weigh in. For patients and advocates, submitting even a short comment is a way to push for transparency and safer food systems.

Other News to Watch

Nightmare bacteria infections are rising, raising alarms about antibiotic resistance. For more information, ask your provider about antibiotic stewardship.

Dose therapy research shows promise in chronic pain relief.

This week’s headlines remind us that energy isn’t only about meals or rest. It’s shaped by research, policy, and access. While there is progress — from new women’s health initiatives to potential FDA reforms — the fragility of these systems remains.

For those living with chronic illness, advocacy, community, and staying informed aren’t just strategies. They’re lifelines.

This Week’s Bright Spot

The Growing Women’s Health Conversation

While women’s health is still underfunded, there are signs the conversation is gaining traction. From new initiatives like the $100M ICONIQ Women’s Health fund, to recent research on PCOS, endometriosis, adenomyosis, and fibroids, the attention is growing louder.

Why it matters: For too long, conditions affecting women have been dismissed, under-researched, or misdiagnosed. This shift signals that women’s health is becoming harder to ignore and that advocacy is working. Every study, every initiative, and every new headline adds weight to a larger cultural shift. Progress may feel slow, but it’s happening. That means more opportunities for better care, better research, and more visibility for women living with chronic illness.

Access Community Resources

We’re building a state-by-state resource hub with vaccine info, SNAP/WIC access, food bank directories, and insurer contacts.

Your input helps make this stronger. If you know a resource that’s helping your community, please share it so others can benefit too.

P.S. – This is an archive of our weekly email. If you’d like to see the email with full content and special offers, please consider subscribing to our newsletter.

References & Further Reading

  • “Infections of Drug-Resistant ‘Nightmare Bacteria’ Are Surging in Hospitals” — Scientific American Scientific American
  • “Nightmare bacteria cases are increasing in the U.S.” — UNMC Health Security University of Nebraska Medical Center
  • “CDC Report Finds Surge in Antibiotic-Resistant Bacteria” — Healthline Healthline
  • “Experimental Painkiller Could Outsmart Opioids – Without High” — Duke University news on SBI-810 Duke University School of Medicine
  • “New Treatments Offer Much-Needed Hope for Patients Suffering from Chronic Pain” — University of Colorado / CU Anschutz CU Anschutz News
  • “A Phase 3 Randomized Placebo-Controlled Trial” — Nature article on VER-01 (chronic lower back pain) Nature
  • “Low-Dose Naltrexone” — Wikipedia summary (caution: secondary source) en.wikipedia.org